Views & Analysis | Perspectives on pharma industry issues

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Patients

pharmaphorum podcast Episode 281 - Cecilia Caetano, Bayer

Sponsored

Menopause is an urgent global health issue: Bayer’s Cecilia ...

Articles

Pharma gets social – social media brings Millennium: The Tak...

Daniel Ghinn’s latest monthly article looks at the use of social media by Milllenium: The Takeda Oncology Company to add value in a niche disease area, such as rare diseases. Over recent months I have compared how selected channels are being used by the world’s largest pharmaceutical companies, with reviews of...

Articles

Strategic portfolio management and new influencers in R&D de...

Dr Christoph Schnorr and Christelle Dujardin discuss strategic portfolio management and the importance of early payer involvement in the product lifecycle. In the healthcare industry, drug developers deal with risk every single day. The question is not so much about how to avoid risk...

Articles

Scotland is blooming with life sciences

Kirsty Smith looks at why spin-outs in Scotland’s life sciences sector are so successful. Scotland has a long-standing and world-class reputation for its research – it is home to one of the UK’s oldest medical schools and is the birth...

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Sales & Marketing

Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital